The Patent Finder

Prothera Biologics, Inc.

Also on record
Records under this name other than the patents Prothera Biologics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.

Back to Prothera Biologics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,932,365Preparation and Composition of Inter-Alpha Inhibitor Proteins from Human Plasma for Therapeutic Use
Surrendered on reissue
Surrendered on reissue May 5, 2020 · High confidence
Surrendered on reissueSurrendered on reissue May 5, 2020High confidence
13/133,000Inhibition of Inter-Alpha Trypsin Inhibitor for the Treatment of Airway Disease
Abandoned
Abandoned Mar 3, 2015
AbandonedAbandoned Mar 3, 2015
14/156,934Methods for Isolating Blood Products from an Inter-Alpha Inhibitor Protein-Depleted Blood Product Material
Abandoned
Abandoned May 24, 2018
AbandonedAbandoned May 24, 2018
14/761,878Methods for Isolating Blood Products from an Inter-Alpha Inhibitor Protein-Depleted Blood Product Material
Abandoned
Abandoned Mar 19, 2018
AbandonedAbandoned Mar 19, 2018
16/331,408Methods for Treating Pulmonary Disease Using Inter-Alpha Inhibitor Proteins
Abandoned
Abandoned Nov 4, 2022
AbandonedAbandoned Nov 4, 2022
16/608,531Methods for Quantifying Inter-Alpha Inhibitor Proteins
Abandoned
Abandoned Aug 23, 2021
AbandonedAbandoned Aug 23, 2021
16/866,241Preparation and Composition of Inter-Alpha Inhibitor Proteins from Human Plasma for Therapeutic Use
Abandoned
Abandoned Sep 29, 2022
AbandonedAbandoned Sep 29, 2022
17/287,952Inter-Alpha Inhibitor Proteins and Methods of Use Thereof
Abandoned
Abandoned Feb 23, 2026
AbandonedAbandoned Feb 23, 2026
17/407,063Inter-Alpha Inhibitor Proteins
Abandoned
Abandoned Jul 25, 2023
AbandonedAbandoned Jul 25, 2023
17/819,591Preparation and Composition of Inter-Alpha Inhibitor Proteins from Human Plasma for Therapeutic Use
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
10 of 12 records shown.
Pro members see all 12.
Pro members: see all 12 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited